Ryo Owaki

Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Restoration of hepatopetal portal flow in a cat with left hepatic arteriovenous malformation following left hepatic division resection and staged attenuation of acquired portosystemic shunts.

Restoration of hepatopetal portal flow in a cat with left hepatic arteriovenous malformation following left hepatic division resection and staged attenuation of acquired portosystemic shunts.

Journal: The Journal of veterinary medical science

Published: July 05, 2026

Effect of fuzapladib sodium hydrate on adhesion molecule expression in canine endothelial cells and neutrophils.

Effect of fuzapladib sodium hydrate on adhesion molecule expression in canine endothelial cells and neutrophils.

Journal: The Journal of veterinary medical science

Published: January 04, 2026

Clinical efficacy of anti-programmed death ligand 1 antibody HFC-L1/c4G12 in dogs with malignant tumors: an exploratory study.

Clinical efficacy of anti-programmed death ligand 1 antibody HFC-L1/c4G12 in dogs with malignant tumors: an exploratory study.

Journal: The Journal of veterinary medical science

Published: October 13, 2025

Successful surgical removal of a retroperitoneal paraganglioma in the celiac artery trifurcation in a dog.

Successful surgical removal of a retroperitoneal paraganglioma in the celiac artery trifurcation in a dog.

Journal: BMC veterinary research

Published: May 05, 2025

Development of caninized anti-CTLA-4 antibody as salvage combination therapy for anti-PD-L1 refractory tumors in dogs.

Development of caninized anti-CTLA-4 antibody as salvage combination therapy for anti-PD-L1 refractory tumors in dogs.

Journal: Frontiers in immunology

Published: February 04, 2025

Enhancement of radio-sensitivity by inhibition of Janus kinase signaling with oclacitinib in canine tumor cell lines.

Enhancement of radio-sensitivity by inhibition of Janus kinase signaling with oclacitinib in canine tumor cell lines.

Journal: Molecular therapy. Oncology

Published: November 06, 2024

Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.

Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.

Journal: PloS one

Published: July 20, 2023

Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma.

Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma.

Journal: Cancers

Published: April 07, 2023

Regulation of programmed death ligand 1 expression by interferon-γ and tumour necrosis factor-α in canine tumour cell lines.

Regulation of programmed death ligand 1 expression by interferon-γ and tumour necrosis factor-α in canine tumour cell lines.

Journal: Veterinary and comparative oncology

Published: October 18, 2022

Unrecognized difficult airway management during anesthesia in two brachycephalic dogs with narrow cricoid cartilage.

Unrecognized difficult airway management during anesthesia in two brachycephalic dogs with narrow cricoid cartilage.

Journal: The Journal of veterinary medical science

Published: January 04, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026